NEW YORK, March 03, 2018 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of MiMedx Group Inc. ("MiMedx") (NASDAQ:MDXG) between March 7, 2013 and February 21, 2018. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of New York. To get more information go to:
http://www.zlk.com/pslra-d/mimedx-group-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) MiMedx was engaged in a “channel-stuffing” scheme designed to inappropriately recognize revenue that had not yet been realized; (ii) the Company lacked adequate internal controls over financial reporting; and (iii) that as a result of the foregoing, MiMedx’s publicly disseminated financial statements were materially false and misleading.
On February 20, 2018, MiMedx announced that it would postpone the release of its financial results and Form 10-K filing for 2017. MiMedx stated it had engaged “independent legal and accounting advisors to conduct an internal investigation into current and prior-period matters relating to the allegations regarding certain sales and distribution practices at the Company.” Following this news, shares of MiMedx fell from a close of $14.47 per share on February 16, 2018 to a close of $8.75 on February 20, 2018.
If you suffered a loss in MiMedx you have until April 25, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com


DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
OpenAI Restricts Astra AI Over Cyberattack Risks
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 



